| Cost-benefit analysis of a thalassemia disease prevention program. JT Ostrowsky, A Lippman, CR Scriver American journal of public health 75 (7), 732-736, 1985 | 95 | 1985 |
| Beta-thalassemia disease prevention: genetic medicine applied. CR Scriver, M Bardanis, L Cartier, CL Clow, GA Lancaster, JT Ostrowsky American journal of human genetics 36 (5), 1024, 1984 | 89 | 1984 |
| Development and deployment of COVID-19 vaccines for those most vulnerable GJ Koff WC, Schenkelberg T, Williams T, Baric RS, McDermott A, Cameron CM ... Science Translational Medicine 13 (579), eabd1525, 2021 | 88 | 2021 |
| A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future MTO KA Moore, JT Ostrowsky, AM Kraigsley, AJ Mehr, JS Bresee, MH Friede, BG ... Vaccine 39 (45), 6573-6584, 2021 | 43 | 2021 |
| Induction of a step in carcinogenesis that is normally associated with mutagenesis by nonmutagenic concentrations of 5-azacytidine N Bouck, D Kokkinakis, J Ostrowsky Molecular and cellular biology 4 (7), 1231-1237, 1984 | 43 | 1984 |
| The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats M Osterholm, K Moore, J Ostrowsky, K Kimball-Baker, J Farrar The Lancet Infectious Diseases 16 (1), e1-e9, 2016 | 27 | 2016 |
| Tracking progress in universal influenza vaccine development J Ostrowsky, M Arpey, K Moore, M Osterholm, M Friede, J Gordon, ... Current opinion in virology 40, 28-36, 2020 | 24 | 2020 |
| A novel approach to enhance food safety: industry-academia-government partnership for applied research MT Osterholm, J Ostrowsky, JA Farrar, RB Gravani, RV Tauxe, ... Journal of food protection 72 (7), 1509-1512, 2009 | 14 | 2009 |
| A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy KA Moore, T Leighton, JT Ostrowsky, CJ Anderson, RN Danila, AK Ulrich, ... Vaccine 41 (13), 2101-2112, 2023 | 10 | 2023 |
| Wellcome Trust-CIDRAP Ebola Vaccine Team B. The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats M Osterholm, K Moore, J Ostrowsky, K Kimball-Baker, J Farrar Lancet Infect Dis 16 (1), e1-9, 2016 | 8 | 2016 |
| Covid-19: The Cidrap Viewpoint MT Osterholm, KA Moore, J Ostrowsky, J Seifert, A Ulrich, A Kraigsley Minneapolis, MN: University of Minesota, 2020 | 5 | 2020 |
| Influenza response planning for the centers of excellence for influenza research and surveillance: Science preparedness for enhancing global health security KA Moore, JT Ostrowsky, AJ Mehr, MT Osterholm, ... Influenza and Other Respiratory Viruses 14 (4), 444-451, 2020 | 4 | 2020 |
| Colloquy: Towards Progress in Food Protection and Defense J Ostrowsky Minn. JL Sci. & Tech. 8, 175, 2007 | 2 | 2007 |
| B-Thalassemia disease prevention: Genetic medicine applied M Bardanis, L Cartier, CL Clow, GA Lancaster, J Ostrowsky, CR Scriver The 7th International Screening Symposium, 1989 | 2 | 1989 |
| Genetic screening, prenatal diagnosis and treatment for beta thalassemia: a cost analysis J Ostrowsky McGill University, 1983 | 2 | 1983 |
| Lassa fever research priorities: towards effective medical countermeasures by the end of the decade KA Moore, JT Ostrowsky, AJ Mehr, RA Johnson, AK Ulrich, NM Moua, ... The Lancet Infectious Diseases, 2024 | | 2024 |
| Measures to prevent and treat Nipah virus disease: research priorities for 2024–29 KA Moore, AJ Mehr, JT Ostrowsky, AK Ulrich, NM Moua, PC Fay, PJ Hart, ... The Lancet Infectious Diseases, 2024 | | 2024 |
| WELLCOME TRUST-CIDRAP Ebola Vaccine Team B M Osterholm, K Moore, J Ostrowsky, K Kimball-Baker, J Farrar J Infect Dis 212 (2), S443-51, 2015 | | 2015 |
| Colloquy: Moving Forward in Food Safety & Defense J Ostrowsky Minnesota Journal of Law, Science & Technology 8 (1), 175, 2006 | | 2006 |
| Response from Ostrowsky, et al JT Ostrowsky, A Lippman, CR Scriver American Journal of Public Health 76 (2), 205-205, 1986 | | 1986 |
